✦ LIBER ✦

929d Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety

✍ Scribed by Lembo, Anthony; Dove, Scott; Andrae, David; Davenport, J. Michael; McIntyre, Gail; Almenoff, June; Covington, Paul S.

Book ID: 122277918
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 50 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60568-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: the safety an

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome – a double-blind, placebo-controlled study

✍ J. F. Tack; P. B. Miner; L. Fischer; M. S. Harris 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

✍ Matsueda, Kei; Harasawa, Shigeru; Hongo, Michio; Hiwatashi, Nobuo; Sasaki, Daisu 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 162 KB

Safety and tolerability of rifaximin for

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials

✍ Schoenfeld, P.; Pimentel, M.; Chang, L.; Lembo, A.; Chey, W. D.; Yu, J.; Paterso 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

701 Efficacy and safety of avanafil for

701 Efficacy and safety of avanafil for the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ J.K. Park; C. Zhao; S.W. Kim; D.Y. Yang; J.J. Kim; N.C. Park; S.W. Lee; J.S. Pai 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Clinical Efficacy, Safety and Tolerabili

Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies

✍ Gelbard, Martin; Goldstein, Irwin; Hellstrom, Wayne J.G.; McMahon, Chris G.; Smi 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 544 KB

Clinical Efficacy, Safety and Tolerabili

Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies

✍ Gelbard, Martin; Goldstein, Irwin; Hellstrom, Wayne J.G.; McMahon, Chris G.; Smi 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 544 KB